FindTrial
Sign In

A study to compare efficacy of biomarkers like serum Adenosine Deaminase and C-reactive protein in patients with and without Diabetic Neuropathy.

Comparision of Serum Adenosine Deaminase and C-reactive protein in Diabetes patients with and without Neuroparhy.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/06/019911
Enrollment
160
Registered
2019-06-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications

Interventions

Control Intervention1: NIL: NIL

Sponsors

kasturba Medical Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The diabetic patient with and without Neuropathy with age ranging from 30 years and above

Exclusion criteria

Exclusion criteria: Diabetes mellitus with other neurological dysfuction, and hypertension, liver, kidney or thyroid disease.

Design outcomes

Primary

MeasureTime frame
Levels of serum ADA in IU/L Levels of serum CRP in mg/lTimepoint: 01 YEAR—

Secondary

MeasureTime frame
RBS, HBA1C.Timepoint: 01 YEAR—

Countries

India

Contacts

Public ContactMansoorkhan

manipal collage of health profession

Anju.muraleedharan@manipal.edu7406765675

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026